Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
Hour-by-Hour Action Plan: Prioritizing Patient Safety, Legal Compliance, and Ethical Leadership Guiding Principle: Patient safety is non-negotiable. Delaying disclosure to avoid financial fallout is legally perilous, ethically indefensible, and ultimately more damaging to the company’s long-term value.Read the full answer